# Treatment Resistant Bipolar Depression

> **NCT00272025** · PHASE1 · TERMINATED · sponsor: **Queen's University** · enrollment: 1 (actual)

## Conditions studied

- Bipolar Depression

## Interventions

- **DRUG:** Escitalopram
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00272025
- **Lead sponsor:** Queen's University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** 2010-01
- **Final completion:** 2010-01
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** Lundbeck withdrew committment - expiring patents and prolonged inactivity
- **Last updated:** 2015-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00272025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00272025, "Treatment Resistant Bipolar Depression". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00272025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*